Patient-derived induced stem cells retain disease traits

December 22, 2008

MADISON - When neurons started dying in Clive Svendsen's lab dishes, he couldn't have been more pleased.

The dying cells - the same type lost in patients with the devastating neurological disease spinal muscular atrophy - confirmed that the University of Wisconsin-Madison stem cell biologist had recreated the hallmarks of a genetic disorder in the lab, using stem cells derived from a patient. By allowing scientists the unparalleled opportunity to watch the course of a disease unfold in a lab dish, the work marks an enormous step forward in being able to study and develop new therapies for genetic diseases.

As reported this week in the journal Nature, Svendsen and colleagues at UW-Madison and the University of Missouri-Columbia created disease-specific stem cells by genetically reprogramming skin cells from a patient with spinal muscular atrophy, or SMA. In this inherited disease, the most common genetic cause of infant mortality, a mutation leads to the death of the nerves that control skeletal muscles, causing muscle weakness, paralysis, and ultimately death, usually by age two.

Genetic reprogramming of skin cells, first reported in late 2007 by UW-Madison stem cell biologists James Thomson and Junying Yu and a Japanese group led by Shinya Yamanaka, turns back the cells' developmental clock and returns them to an embryonic-like state from which they can become any of the body's 220 different cell types. The resulting induced pluripotent stem cells, known as iPS cells, harness the blank-slate developmental potential of embryonic stem cells without the embryo and have been heralded as a powerful potential way to study development and disease.

Just one year later, the new work is fulfilling that promise.

"When scientists study diseases in humans, they can normally only look at the tissues affected after death and then try to work out - how did that disease happen? It's a little like the police arriving at the scene of a road accident - the car's in the ditch, but they don't know how it got there or the cause of it," explains Svendsen, a professor of anatomy and neurology in the UW-Madison School of Medicine and Public Health and the Waisman Center, and co-director of the Stem Cell and Regenerative Medicine Center.

With iPS cells, he says, "Now you can replay the human disease over and over in the dish and ask what are the very early steps that began the process. It's an incredibly powerful new tool."

In the new study, the researchers created iPS cells from stored skin cells of a young SMA patient and his mother, who does not have the disease. The cells grew well in the lab, and the group developed a new method to efficiently drive them to make large numbers of motor neurons, the cells that control muscles and that are affected in SMA.

Initially, the motor neurons thrived in both samples. But after about a month, "the accident started happening," Svendsen says, and the motor neurons from the patient-derived cells began to disappear.

"The motor neurons we got started to die in culture, just like they do in the disease. This is the first validation of a human disease that we've modeled in a culture dish," he says.

They can now begin to dissect what kills the motor neurons and why these cells alone are targeted in the disease. Past studies to understand the effects of the SMA-causing mutation have often relied on the easy-to-obtain skin cells, which are not affected in SMA and offer limited insight into how and why motor neurons die, says UW-Madison researcher Allison Ebert, lead author on the new study.

"If we start to understand more of the mechanism of why the motor neurons specifically affected in the disease are dying, then potentially new therapies can be developed to intervene at particular times early in development," she explains. Current SMA treatment options are limited, and there is no cure.

Ebert points out that the patient-derived iPS cells can offer scientific advantages over other approaches, including embryonic stem cells, for studying disease. In effect, the researchers can watch the unfolding of an accident that has already occurred, and the known clinical outcome - the course and severity of the patient's disease - should help them understand how the changes they see in the cells fit into the bigger picture of the disease.

"The development of human-derived SMA motor neurons is an important step forward for the SMA field, especially as a variety of therapeutic avenues are being examined," agrees SMA expert Christian Lorson, a professor of veterinary pathobiology at MU and an author on the paper. "To be able to investigate therapeutic activity in these cells, whether it be novel drugs, viral vectors, oligonucleotides, or a better understanding of disease pathology, the iPS SMA motor neurons represent an excellent disease-related context."

While complex and late-hitting disorders like Alzheimer's and Parkinson's diseases will be harder to model with iPS cells, the researchers say the approach should pave the way for studies of other genetic disorders, such as Huntington's disease. "We have to find better ways to model complex human diseases that are difficult to reproduce in animals," Svendsen says. "iPS cells represent a promising new research tool to reach this goal."

He credits the UW-Madison Stem Cell and Regenerative Medicine Center with facilitating the work, especially by drawing on the expertise of Yu and Thomson, who pioneered the technique, to create the iPS cells used in this study. "This is an example of how the center is working to collaborate on campus and off campus to bring these kind of things to fruition," he says.

University of Wisconsin-Madison

The Official Parent's Sourcebook on Spinal Muscular Atrophy: A Revised and Updated Directory for the Internet Age
by Icon Health Publications (Author)

This sourcebook has been created for parents who have decided to make education and Internet-based research an integral part of the treatment process. Although it gives information useful to doctors, caregivers and other health professionals, it also tells parents where and how to look for information covering virtually all topics related to spinal muscular atrophy, from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on spinal muscular atrophy. Following an introductory chapter, the sourcebook is...

Life Rolls On
by Rich Ochoa (Author), Duane Hale (Author)

When he was four years old, doctors told Duane Hale's parents that their son had Spinal Muscular Atrophy and that he wouldn't live past his teens. That was forty-two years ago and he has now outlived some of those doctors. What happens to a rambunctious little boy whose disease turns him into a man who can't move? How does such a man graduate high school as Student of the Year, work twenty years for the police department, buy a house, get married, father and raise a son? This is the story of a man and the strength he derives from his family and his community. Even as the disease paralyzes more of his body every day his spirit stays strong and Life Rolls On.

Living with Spinal Muscular Atrophy: The True Story of Kassidy Jade Sears
by Trina Allen (Author)

Kassidy was born into the world just months prior to the soon to be roller-coaster ride her young parents would face. Kassidy was the only child and the only grandchild at this time, which seemed healthy and happy. Such devastating news would soon follow the day she turned three months old. The strength and courage that Kassidy had will never be forgotten. The love that this little girl had for her mommy and the love that her mommy had for her will always be remembered. The question we all asked "Why God? Why us? Why our Kassidy?" a question that we still ask today and will for years to come.

The Jeffrey Journey - 2010 Edition
by Milverstead Publishing

Revised and Updated - 2010 with new resources and dedications. In May, 1997, Randy and Helen Baldwin eagerly welcomed their third child, Jeffrey, as did his older siblings, Matthew and Katie. Jeffrey's arrival, unplanned but greatly anticipated, sparked a few adjustments in this family long removed from diaper duty, but Jeffrey was obviously a special gift. Eight weeks later, life took a completely unexpected downward spiral into the depths of despair when Jeffrey was diagnosed with Spinal Muscular Atrophy (SMA), a rare, progressive genetic neuromuscular disease with deadly ramifications. The neurologist handed over the utterly devastating news that Jeffrey had a severe case of the most destructive form without a morsel of hope that anything could be done to thwart the effects of the...

Progressive Spinal Muscular Atrophies (The International Review of Child Neurology)
by Ingrid Gamstorp (Author)

Current Concepts in Childhood Spinal Muscular Atrophy
by Luciano Merlini (Editor), Claudia Granata (Editor), Victor Dubowitz (Editor)

Spinal Muscular Atrophy: Infantile and Juvenile Type
by Irena Hausmanowa-Petrusewicz (Author)

Nutrition issues associated with spinal muscular atrophy. (Review).: An article from: Nutrition & Dietetics: The Journal of the Dieticians Association of Australia
by Sarah Leighton (Author)

This digital document is an article from Nutrition & Dietetics: The Journal of the Dieticians Association of Australia, published by Thomson Gale on June 1, 2003. The length of the article is 4286 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Nutrition issues associated with spinal muscular atrophy. (Review).
Author: Sarah Leighton
Publication: Nutrition & Dietetics: The Journal of the Dieticians Association of Australia (Magazine/Journal)
Date: June 1, 2003
Publisher: Thomson Gale
Volume: 60 Issue: 2 Page: 92(5)

Distributed by Thomson...

Spinal muscular atrophy: An entry from Thomson Gale's Gale Encyclopedia of Neurological Disorders
by Borut, MD, PhD Peterlin (Author)

Targeted to patients, their families and allied health students, The “Gale Encyclopedia of Neurological Disorders” provides in-depth coverage of neurological diseases and disorders, including stroke, multiple sclerosis, Parkinson disease, Tourette Syndrome, Alzheimer's disease, cerebral palsy, vertigo, amnesia and epilepsy. Related topics include communication aids, electric personal assistive mobility devices, medications for treating neurological diseases and conditions, understanding the needs of Alzheimer patient caregivers and more. This two-volume set provides an alternative to resources that either fail to explore neurological disease in any depth and or do so at a level not appropriate for students and general readers.

Spinal muscular atrophy: An entry from Thomson Gale's Gale Encyclopedia of Children's Health: Infancy through Adolescence
by Rosalyn, MD Carson-DeWitt (Author)

Avoiding hard-to-understand medical jargon, the four-volume “Gale Encyclopedia of Children’s Health” uses language that parents can understand, while still providing enough depth to benefit today's health science students. The set provides in-depth coverage of pediatric diseases and disorders, along with issues related to physical and cognitive/behavioral development.